Revive Therapeutics Valuation
| RVVTF Stock | USD 0.01 0.0009 15.00% |
Revive Therapeutics seems to be overvalued based on Macroaxis valuation methodology. Our model determines the value of Revive Therapeutics from analyzing the company fundamentals such as Shares Owned By Institutions of 2.42 %, return on equity of -0.83, and Shares Outstanding of 353.56 M as well as examining its technical indicators and probability of bankruptcy. . In general, most investors support locking in undervalued entities and disposing overvalued entities since, at some point, asset prices and their ongoing real values will merge together.
Overvalued
Today
Please note that Revive Therapeutics' price fluctuation is out of control at this time. Calculation of the real value of Revive Therapeutics is based on 3 months time horizon. Increasing Revive Therapeutics' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Revive otc stock is determined by what a typical buyer is willing to pay for full or partial control of Revive Therapeutics. Since Revive Therapeutics is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Revive OTC Stock. However, Revive Therapeutics' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.0069 | Real 0.006366 | Hype 0.008415 |
The real value of Revive OTC Stock, also known as its intrinsic value, is the underlying worth of Revive Therapeutics OTC Stock, which is reflected in its stock price. It is based on Revive Therapeutics' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Revive Therapeutics' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Revive Therapeutics helps investors to forecast how Revive otc stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Revive Therapeutics more accurately as focusing exclusively on Revive Therapeutics' fundamentals will not take into account other important factors: Revive Therapeutics Total Value Analysis
Revive Therapeutics is at this time anticipated to have takeover price of 32.12 M with market capitalization of 36.1 M, debt of 60 K, and cash on hands of 5.29 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Revive Therapeutics fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
32.12 M | 36.1 M | 60 K | 5.29 M |
Revive Therapeutics Asset Utilization
One of the ways to look at asset utilization of Revive is to check how much profit was generated for every dollar of assets it reports. Revive Therapeutics holds a negative application of assets of -0.43 pct., losing $0.004252 for each dollar of assets held by the company. Inadequate asset utilization implies the company is being less effective with each dollar of assets it holds. Put it differently, asset utilization of Revive Therapeutics shows how discouraging it operates for each dollar spent on its assets.Revive Therapeutics Ownership Allocation
Revive Therapeutics owns a total of 353.56 Million outstanding shares. Roughly 95.1 pct. of Revive Therapeutics outstanding shares are held by general public with 2.48 % owned by insiders and only 2.42 (%) by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Revive Therapeutics Profitability Analysis
Net Loss for the year was (17.81 M) with profit before overhead, payroll, taxes, and interest of 0.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Revive Therapeutics' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Revive Therapeutics and how it compares across the competition.
About Revive Therapeutics Valuation
The otc valuation mechanism determines Revive Therapeutics' current worth on a weekly basis. Our valuation model uses a comparative analysis of Revive Therapeutics. We calculate exposure to Revive Therapeutics's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Revive Therapeutics's related companies.Revive Therapeutics Ltd., a life sciences company, focuses on the research and development of therapeutics for rare disorders and infectious diseases. The company was incorporated in 2012 and is headquartered in Toronto, Canada. Revive Therapeutics is traded on OTC Exchange in the United States.
8 Steps to conduct Revive Therapeutics' Valuation Analysis
OTC Stock's valuation is the process of determining the worth of any otc stock in monetary terms. It estimates Revive Therapeutics' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of otc stock valuation is a single number representing a OTC Stock's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Revive Therapeutics' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Revive Therapeutics' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Revive Therapeutics' revenue streams: Identify Revive Therapeutics' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Revive Therapeutics' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Revive Therapeutics' growth potential: Evaluate Revive Therapeutics' management, business model, and growth potential.
- Determine Revive Therapeutics' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the OTC Stock's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Revive Therapeutics' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Revive Therapeutics Growth Indicators
Investing in growth stocks can be very risky. If the company such as Revive Therapeutics does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 321.4 M | |
| Retained Earnings | -54.2 M |
Complementary Tools for Revive OTC Stock analysis
When running Revive Therapeutics' price analysis, check to measure Revive Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Revive Therapeutics is operating at the current time. Most of Revive Therapeutics' value examination focuses on studying past and present price action to predict the probability of Revive Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Revive Therapeutics' price. Additionally, you may evaluate how the addition of Revive Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |